The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor

Journal of Clinical Investigation

Volumn 100, Issue 9, 1997, Pages 2170-2181

  Argraves, Kelley McTigue ^a   Kozarsky, Karen F ^b   Fallon, John T ^c   Harpel, Peter C ^c,e   Strickland, Dudley K ^a,d  

^a HOLLAND LABORATORY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d AMERICAN RED CROSS   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Adenovirus; Atherosclerosis; Endocytosis; Endothelium; Macrophage

Indexed keywords

LIPOPROTEIN A; LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; ENDOCYTOSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0030666519     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119753     Document Type: Article

References (67)

1. Schaefer, E.J., S. Lamno-Fava, J.L. Jenner, J.R. McNamara, J.M. Ordovas, C.E. Davis, J.M. Abolafia, K. Lippel, and R.I. Levy. 1994. Lipoprotein(a) levels and risk of coronary heart disease in men. JAMA. 271:999-1003.
2. Utermann, G. 1990. The mysteries of Lp(a) lipoprotein. Science (Wash. DC). 246:904-910.
3. Bostom, A.G., L.A. Cupples, J.L. Jenner, J.M. Ordovas, L.J. Seman, P.W.F. Wilson, E.J. Schaefer, and W.P. Castelli. 1996. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. JAMA. 276:544-548.
4. McLean, J.W., J.E. Tomlinson, W. Kuang, D.L. Eaton, E.Y. Chen, G.M. Fless, A.M. Scanu, and R.M. Lawn. 1987. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature (Lond.). 330:132-137.
5. Lackner, C., J.C. Cohen, and H.H. Hobbs. 1993. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum. Mol. Genet. 2:933-940.
6. Gaw, A., and H.H. Hobbs. 1994. Molecular genetics of lipoprotein(a): new pieces to the puzzle. Curr. Opin. Lipidol. 5:149-155.
7. Miles, L.A., G.M. Fless, E.G. Levine, A.M. Scanu, and E.F. Plow. 1989. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature (Lond.). 339:301-303.
8. Hajjar, K.A., D. Gavish, J.L. Breslow, and R.L. Nachman. 1989. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature (Lond.). 339:303-305.
9. Kojima, S., P.C. Harpel, and D.B. Rifkin. 1991. Lipoprotein(a) inhibits the generation of transforming growth factor-∃: an endogenous inhibitor of smooth muscle cell migration. J. Cell Biol. 113:1439-1445.
10. Lawn, R.M., D.P. Wade, R.E. Hammer, G. Chiesa, J.G. Verstuyfl, and E.M. Rubin. 1992. Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature (Lond.). 360:670-672.
11. Grainger, D.J., P.R. Kemp, A.C. Lui, R.M. Lawn, and J.C. Metcalfe. 1994. Activation of transforming growth factor-∃ is inhibited in transgenic apolipoprotein(a) mice. Nature (Lond.). 370:460-462.
12. Brown, M.S., and J.L. Goldstein. 1987. Plasma lipoproteins: teaching old dogmas new tricks. Nature (Lond.). 330:113-114.
13. Brown, M.S., and J.L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science (Wash. DC). 232:34-47.
14. Hofmann, S.L., D.L. Eaton, M.S. Brown, W.J. McConathy, J.L. Goldstein, and R.E. Hammer. 1990. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J. Clin. Invest. 85:1542-1547.
15. Rader, D.J., W.A. Mann, W. Cain, H. Kraft, D. Usher, L.A. Zech, J.M. Hoeg, J. Davignon, P. Lupien, M. Grossman, et al. 1995. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J. Clin. Invest. 95:1403-1408.
16. Bottalico, L.A., G.A. Keesler, G.M. Fless, and I. Tabas. 1993. Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoprotein(a) internalization and degradation. J. Biol. Chem. 268: 8569-8573.
17. Marz, W., A. Beckmann, H. Scharnagl, R. Siekmeier, U. Mondorf, I. Held, W. Schneider, K.T. Preissner, L.K. Curtiss, and W. Gross. 1993. Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. FEBS Lett. 325:271-275.
18. Strickland, D.K., M.Z. Kounnas, and W.S. Argraves. 1995. LDL receptor-related protein: A multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 9:890-898.
19. Krieger, M., and J. Herz. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:601-637.
20. 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands. Biochem. Biophys. Acta. 1197:197-213.
21. 2-macroglobulin receptor/ low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. J. Biol. Chem. 267:9035-9040.
22. 2-macroglobulin receptor and glycoprotein 330. J. Biol. Chem. 267:21162-21166.
23. Orlando, R.A., D. Kerjaschki, H. Kurihara, D. Biemesderfer, and M.G. Farquhar. 1992. gp330 Associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex. Proc. Natl. Acad. Sci. USA. 89: 6698-6702.
24. Battey, F., M.E. Gåfvels, D.J. Fitzgerald, W.S. Argraves, D.A. Chappell, J.F. Strauss III, and D.K. Strickland. 1994. The 39 kDa receptor associated protein regulates ligand binding by the very low density lipoprotein receptor. J. Biol. Chem. 269:23268-23273.
25. Medh, J.D., G.L. Fry, S.L. Bowen, M.W. Pladet, D.K. Strickland, and D.A. Chappell. 1995. The 39 kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J. Biol. Chem. 270:536-540.
26. Harpel, P.C., B.R. Gordon, and T.S. Parker. 1989. Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc. Natl. Acad. Sci. USA. 86:3847-3851.
27. Marcovina, S.M., H.H. Hobbs, and J.J. Albers. 1996. Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin. Chem. 42:436-439.
28. Edelstein, C., M. Mandala, and A.M. Scanu. 1995. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions. Biochemistry. 34:16483-16492.
29. Argraves, K.M., F.D. Battey, C.D. MacCalman, K.R. McCrae, M. Gåfvels, K.F. Kozarsky, D.A. Chappell, J.F. Strauss, and D.K. Strickland. 1995. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J. Biol. Chem. 270:26550-26557.
30. Bilheimer, D.W., S. Eisenberg, and R.I. Levy. 1972. The metabolism of very low density lipoproteins. I. Preliminary in vitro and in vivo observations. Biochem. Biophys. Acta. 260:212-221.
31. Willnow, T.E., and J. Herz. 1994. Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A: evidence that this protein is required for uptake and degradation of multiple ligands. J. Cell Sci. 107:719-726.
32. Stefansson, S., D.A. Chappell, K.M. Argraves, D.K. Strickland, and W.S. Argraves. 1995. Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein B100. J. Biol. Chem. 270:19417-19421.
33. Wittmaack, F.M., M. Gåfvels, M. Bronner, H. Matsuo, K. McCrae, J. Tomaszewski, S.L. Robinson, D.K. Strickland, and J.F.I. Strauss. 1995. Localization and regulation of the human VLDL/ApoE receptor: trophoblast expression predicts a role for the receptor in placental lipid transport. Endocrinology. 136:340-348.
34. 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J. Biol. Chem. 267:12420-12423.
35. Milne, R.W., R.J. Theolis, R.B. Verdery, and Y.L. Marcel. 1983. Characterization of monoclonal antibodies against human low density lipoprotein. Arteriosclerosis. 3:23-30.
36. 2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay. J. Clin. Invest. 68:46-55.
37. Voller, A., D.E. Bidwell, and A. Bartlett. 1976. Microplate enzyme immunoassays for the immunodiagnosis of virus infections. In Manual of Clinical Immunology. N.R. Rose and H. Freedman, editors. American Society of Microbiology, Washington, D.C. 506-512.
38. Kozarsky, K.F., K. Jooss, M. Donahae, J.F. Strauss, and J.M. Wilson. 1996. Effective and persistent treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nat. Genet. 13:54-62.
39. Forsayeth, J.R., and P.D. Garcia. 1994. Adenovirus-mediated transfection of cultured cells. Biotechniques. 17:354-359.
40. 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J. Biol. Chem. 267:25764-25767.
41. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal. Biochem. 72:248-255.
42. Frykman, P.K., M.S. Brown, T. Yamamoto, J.L. Goldstein, and J. Herz. 1995. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92:8453-8457.
43. Becker, T.C., R.J. Noel, W.S. Coats, A.M. Gomex-Foix, T. Alam, R.D. Gerard, and C.B. Newgard. 1994. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43:161-189.
44. Simonsen, A.C.W., C.W. Heegard, L. Rasmussen, K., L. Ellgaard, L. Kjoller, A. Christensen, M. Etzerodt, and P.A. Andreasen. 1994. Very low density lipoprotein receptor from mammary gland and mammary epithelial cell lines binds and mediates endocytosis of Mr 40000 receptor associated protein. FEBS Lett. 354:279-283.
45. Kounnas, M.Z., R.D. Moir, G.W. Rebeck, A.I. Bush, W.S. Argraves, R.E. Tanzi, B.T. Hyman, and D.K. Strickland. 1995. LDL receptor-related protein, a multifunctional apoE receptor, binds secreted ∃-amyloid precursor protein and mediates its degradation. Cell. 82:331-340.
46. Heegaard, C.W., A.C.W. Simonsen, K. Oka, L. Kjoller, A. Christensen, B. Madsen, L. Ellgaard, L. Chan, and P.A. Andreasen. 1995. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex. J. Biol. Chem. 270:20855-20861.
47. Takahashi, S., Y. Kawarabayasi, T. Nakai, J. Sakai, and T. Yamamoto. 1992. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA. 89:9252-9256.
48. Suzuki, J., S. Takahashi, K. Oida, A. Shimada, M. Kohno, T. Tamai, S. Miyabo, T. Yamamoto, and T. Nakai. 1995. Lipid accumulation and foam cell formation in Chinese hamster ovary cells overexpressing very low density lipoprotein receptor. Biochem. Biophys. Res. Commun. 206:835-842.
49. Utermann, G., H.J. Menzel, H.G. Kraft, H.C. Duba, H.G. Kemmler, and C. Seitz. 1987. Lp(a) glycoprotein phenotypes: inheritance and correlation to Lp(a)-lipoprotein concentrations in plasma. J. Clin. Invest. 80:458-465.
50. Lackner, C., E. Boerwinkle, C.C. Leffert, T. Rahmig, and H.H. Hobbs. 1991. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J. Clin. Invest. 87:563-567.
51. Marcovina, S.M., J.J. Albers, B. Gabel, M.L. Koschinsky, and V.P. Gaur. 1995. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin. Chem. 41:246-255.
52. Gåfvels, M.E., L.G. Paavola, C.O. Boyd, P.M. Nolan, F. Wittmaack, J. Chawla, M.A. Lazar, J. Bucan, B. Angelin, and J.F. Strauss III. 1994. Cloning of a complementary deoxyribonucleic acid encoding the murine homolog of the very low density lipoprotein/apolipoprotein-E receptor: expression pattern and assignment of the gene to mouse chromosome 19. Endocrinology. 135:387-394.
53. Mooser, V., M.C. Seabra, M. Abedin, K. Landschulz, S. Marcovina, and H.H. Hobbs. 1996. Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). J. Clin. Invest. 97:858-864.
54. Rath, M., A. Niendorf, T. Reblin, M. Dietel, H. Krebber, and U. Beisiegel. 1989. Detection and quantitation of lipoprotein(a) in the arterial wall of 107 cororary bypass patients. Arteriosclerosis. 9:579-592.
55. Wyne, K.L., R.K. Pathak, M.C. Seabra, and H.H. Hobbs. 1996. Expression of the VLDL receptor in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 16:407-415.
56. Multhaupt, H.A.B., M.E. Gåfvels, K. Kariko, H. Jin, C. Arenas-Elliott, B.I. Goldman, J.F.I. Strauss, B. Angelin, M.J. Warhol, and K.R. McCrae. 1996. Expression of very low density lipoprotein receptor in the vascular wall: analysis of human tissues by in situ hybridization and immunohistochemistry. Am J. Pathol. 148:1985-1997.
57. Mikhailenko, I., D. Krylov, K.M. Argraves, D.D. Roberts, G. Liau, and D.K. Strickland. 1997. Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein. J. Biol. Chem. 272:6784-6791.
58. Jamiseon, D.G., D.C. Usher, D.J. Rader, and E. Lavi. 1995. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. Am. J. Pathol 147:1567-1574.
59. Webb, J.C., D.D. Patel, M.D. Jones, B.L. Knight, and A.K. Soutar. 1994. Characterization and tissue-specific expression of the human very low density lipoprotein (VLDL) receptor. Hum. Mol. Genet. 3:531-537.
60. Gåfvels, M.E., M. Caird, D. Britt, C.L. Jackson, D. Patterson, and J.F. Strauss, III. 1993. Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23. Somatic Cell Mol. Genet. 19:557-569.
61. Ross, R. 1993. The pathogeneis of atherosclerosis: a perspective for the 1990s. Nature (Lond.). 362:801-809.
62. Sakai, J., A. Hoshino, S. Takahashi, Y. Miura, H. Ishii, H. Suzuki, Y. Kawarabayasi, and T. Yamamoto. 1994. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J. Biol. Chem. 269:2173-2182.
63. Zioncheck, T.F., L.M. Powell, G.C. Rice, D.L. Eaton, and R.M. Lawn. 1991. Interaction of recombinant apolipoprotein(a) and lipoprotein (a) with macrophages. J. Clin. Invest. 87:767-771.
64. Snyder, M.L., D. Polacek, A.M. Scanu, and G.M. Fless. 1992. Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages. J. Biol. Chem. 267:339-346.
65. Masuzaki, H., H. Jingami, T. Yamamoto, and K. Nakao. 1994. Effects of estradiol on very low density lipoprotein receptor mRNA levels in rabbit heart. FEBS Lett. 347:211-214.
66. Jokinen, E.V., K.T. Landschulz, K.L. Wyne, Y.K. Ko, P.K. Frykman, and H.H. Hobbs. 1994. Regualtion of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J. Biol. Chem. 269:26411-26418.
67. Ishibashi, T., K. Yokoyama, J. Shindo, Y. Hamazaki, Y. Endo, T. Sato, S. Takahashi, Y. Kawarabayasi, M. Shiomi, T. Yamamoto, and Y. Maruyama. 1994. Potent cholesterol-lowering effect by human granulocyte-macrophage colony-stimulating factor in rabbits: possible implications of enhancement of macrophage functions and an increase in mRNA for VLDL receptor. Arterioscler. Thromb. 14:1534-1541.